Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel furfural-based route offers high selectivity and mild conditions for 5-AP production ensuring cost reduction in pharma intermediate manufacturing and supply stability.
Patent CN115028598A details a novel Pd-catalyzed route for benzoxazine intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical applications.
Novel magnetic nanoparticle catalyst enables high-purity 4,4'-dichlorobenzenesulfone production with simplified recovery and reduced waste for industrial scale.
Patent CN106995373A reveals high-yield nitroolefin synthesis using ammonium iodide. This method offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN111778297B details a high-yield enzymatic route for chiral piperidine intermediates. Discover cost-effective manufacturing and supply chain advantages.
Patent CN117003642A reveals a novel route for Ensitrelvir intermediates. Achieve high purity and reduced costs with scalable pharmaceutical intermediate manufacturing strategies.
Novel total synthesis route for Oxonantenine offers high purity and scalable production for antitumor drug development supply chains.
Novel alkali metal halide catalyzed method ensures stable quality and high yield for hydrocortisone acetate manufacturing supply chain efficiency.
Patent CN104263796A details a high-yield chiral synthesis route. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Novel patented route for high-purity nucleoside intermediates. Enhances solubility and yield for nucleic acid drug manufacturing supply chains.
Patent CN111377982B details a novel solid acid catalyzed glycosylation for decitabine intermediates, offering high beta-selectivity and simplified purification for pharmaceutical manufacturing.
Novel synthesis route for hypoglycemic drug molecule TAPA offering high yield and scalable production for pharmaceutical intermediate supply chains globally.
Patent CN112538068A reveals a novel acid-catalyzed route for electron-rich heterocycles, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN108017594B reveals a safer one-pot synthesis replacing carbon disulfide, offering cost reduction and environmental benefits for pharmaceutical intermediates manufacturing.
Novel organophosphine-catalyzed asymmetric [4+2] cycloaddition for high-purity chiral 3,4-dihydroquinazolin-2-ones. Scalable route with excellent enantioselectivity up to 92% ee.
Novel catalytic oxidation process for 4-HMFA and 2 4-FDCA offering enhanced purity and scalable production capabilities for global supply chains.
Novel patent CN105873938A details a high-yield regadenoson process avoiding genotoxic impurities ensuring supply chain stability and cost reduction in API manufacturing.
Patent CN105483749A details a green pairwise electrosynthesis method for pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN103044315A reveals solvent-free 1,4-dihydropyridine synthesis. Acidic ionic liquid catalyst ensures high yield and supply chain reliability for pharmaceutical intermediates.
Patent CN104529803B reveals a novel amide synthesis route using triethylenediamine. Achieve cost reduction in pharmaceutical intermediates manufacturing with high purity.